An interventional study of Fall and dementia prevention exercise in Dementia, Mild, Accidental Falls and Mild Cognitive Impairment, sponsored by Sunmi Song. Recruiting at 1 site in South Korea. Open to participants aged 65 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-03-20.
Sponsored by Sunmi Song · Not applicable, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 52 studies in Dementia with a site in Korea, Republic of — 15 open to participants now, 18 under way, 4 of them phase 3. Dementia · Korea, Republic of.
Among the 52 studies in Dementia with a site in Korea, Republic of, this one is the 23rd largest by planned enrollment of the 43 interventional ones that give a count, is one of 6 that started in 2024, is one of 13 with no phase, reaches primary completion later than 4 of the 17 other live ones, and was the 39th registered.
2,377 studies on the registry are indexed under Dementia; 572 are open to participants now.
Browse Dementia studies →15 of the 52 studies in Dementia with a site in Korea, Republic of are open now. Recruiting first, the newest first:
Chungnam National University · Sites in Korea, Republic of
Ages 19+
MapLight Therapeutics · Sites in Korea, Republic of, United States, Argentina and 12 more countries
Ages 55–90
GlaxoSmithKline · Sites in Korea, Republic of, United States, Argentina and 8 more countries
Ages 50–85
Bristol-Myers Squibb · Sites in Korea, Republic of, United States, Argentina and 16 more countries
Ages 60–85
Korea University · Sites in Korea, Republic of
Ages 60+ · Healthy volunteers
A study can be open while its sites in Korea, Republic of have not opened yet or have stopped. Only those recruiting at a site in Korea, Republic of →
Of the 382 Dementia studies recruiting now, 242 (63%) set no upper age limit and 25 (7%) stop at 75 or younger; 15 take children under 18; 163 take healthy volunteers.
This study: 65 Years and older · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
52 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 2 · Phase 2 11 · Phase 3 18 · Phase 4 3
First in 2003; this study’s year is marked. 6 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 205 is above the median of 90 across 1,761 interventional studies indexed under Dementia.
Median enrollment 220 across the 43 interventional studies, 163 across the 9 observational. Of the 28 that completed or were terminated, 8 (29%) have results posted.
This tab as a report to print or save as PDF → With an account.
30 of 52 have an industry lead sponsor. The 10 most frequent:
Sunmi Song is the lead sponsor of 2 studies on the registry; 2 are open to participants now.
Sunmi Song has 1 study filed under Dementia — fewer than ten, so there is no comparison to draw.
5 of the studies in Dementia with a site in Korea, Republic of that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06268886Bristol-Myers SquibbStudy to Evaluate the Efficacy, Safety, and Tolerability of an Anti-MTBR Tau Monoclonal Antibody (BMS-986446) in Participants With Early Alzheimer's Disease | 2026-12-17 |
| NCT06664229Sunmi SongDevelopment of Pressure Sensor Based Dementia and Fall Prevention Program for Older Adults | 2026-12-31 |
| NCT07328386Hong JoonpioEffect of Cervical Lymphaticovenous and Lymph Node-to-Vein Anastomosis in Patients With Intracranial Lymphatic Circulation Disorder | 2026-12-31 |
| NCT06088121Advanced Technology & CommunicationsStudy to Evaluate the Efficacy and Safety of ATNC-MDD V1(TMS With Cognitive Training) in Mild Alzheimer's Dementia | 2027-01-15 |
| NCT07485387Korea UniversityGlobal Collaborative Research on Establishing a Korean Cognitive Aging Cohort | 2027-04-30 |
Add all 5 to your calendar (.ics) → With an account.
Among the 52 studies in Dementia with a site in Korea, Republic of, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The goal of this intervention program is to test the effectiveness of pressure sensor based dementia and fall prevention program for improving cognitive and physical functions of community dwelling older adults. The main purposes of this study are:
Older adults will be asked to participate in a group training session that was lead by a fitness coach using a pressure sensor mat, a standing monitor, and a linked software programs. They will be asked to stand on the mat, which is set in front of a monitor to show positions of the mat where they place their foots. The monitor screen will guide them to conduct either a balancing exercise for fall prevention or a cognitive exercise such as memory game or quiz game for dementia prevention.
Researchers will compare age and gender matched control group in a main study to see if cognitive and balancing functions of intervention group is better than the control group by conducting pre and post surveys and physical examinations. A pilot study will examine pre-post changes in the intervention group without the control group.
A. Developed group exercise devices
○ The study will test the flexible, stretchable film-type pressure sensor embedded balance mat and a monitor that will present a sequence of fitness programs and cognitive tasks.
B. Pilot Test
C. The main test
The main test will be conducted with single-blind, randomized controlled trial (RCT) design. The intervention group will participate in the group exercises using the developed devices that are led by a trainer.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Older adults who participated in a group exercise program using the developed mat and software three times per week for six weeks (18 sessions) for a pilot study and twelve weeks (36 sessions) for a main study took part in the pre-post tests. The frequency and duration can be adjusted to twice per week for nine weeks (18 sessions) for a pilot study or twice per week for sixteen weeks (32 sessions) for a main study to accommodate the availability of participants and the spaces in the community center.
Behavioral: Fall and dementia prevention exercise
Older adults who participated only in the pre-post tests without receiving any intervention.
The fall and dementia prevention exercise is designed as a combination of balancing and cognitive exercise and games that is conducted as a group activity. The session will be provided three times per week for six weeks for a pilot test and three times per week for 12 weeks for a main comparison study. The fall prevention exercise involves the pressure mat based balancing exercise such as side stepping, heel or toe standing, and quarter squat. The safety bar will be placed around the mat, so that older adults with instability can hold while they follow the movements. The cognitive exercise will concise of multiple types of cognitive tasks to train memory, numeric processing, spatial perception, and logical thinking. For example, memory task such as memorizing the series of positions on the screen and use the mat to point the positions in the right order. At the end, older adults play games in which they use balancing movements and cognitive tasks to gain scores for their team.
The Mini-Mental State Exam Korean Version (MMSE-K)
The Mini-Mental State Exam Korean version (MMSE-K) ranges from 0-30 with higher score indicating better cognitive function.
Time frame: The system usability test will be conducted at baseline and within one week following the last session of the intervention.
The Berg Balance test
The Berg Balance test (Lusardi, 2004) ranges from 0 to 56 with lower score indicating the more risk of losing one's balance.
Time frame: The Berg balance test will be conducted at baseline (one week before the first session), mid-term survey (6th week of 12 week program or 8th week of 16 week program), and within one week following the last session of the intervention (13th or 17th week).
Sarcopenia index
Sarcopenia-related measures, including appendicular skeletal muscle mass (ASM), appendicular skeletal muscle mass index (ASMI), and handgrip strength, were assessed according to the Asian Working Group for Sarcopenia 2019 criteria
Time frame: The test will be conducted at baseline, and at the mid-term assessment, and within one week following the last session of the intervention.
The figure of 8 walk test
The figure of 8 walk test measures the time (seconds) to walk a figure-of-eight around 2 cones placed 2.4 m apart twice. The smaller score indicates the better walking ability of a participant.
Time frame: The figure of 8 walk test will be conducted at baseline, mid-term survey, and within one week following the last session of the intervention.
The 3 m sit-walk and return test
The 3 m sit-walk and return test measures the time (seconds) from sitting on a chair to standing, walking to a 3 m target, and then returning to the chair and sitting down. The shorter test score indicates better fitness of a participant.
Time frame: The 3 m sit-walk and return test will be conducted at baseline, mid-term survey, and within one week following the last session of the intervention.
The 30 second sit-stand test
The 30 second sit-stand test measures the number of completed chair stands in 30 seconds. The larger number of completed chair stands, the better physical fitness of a participant.
Time frame: The 30 second sit-stand test will be conducted at baseline, mid-term survey, and within one week following the last session of the intervention.
Montreal Cognitive Assessment (MoCA)
MoCA test will be conducted to examine changes in cognitive functioning before and after the intervention program in addition to MMSE.
Time frame: MoCA will be conducted at baseline and within one week following the last session of the intervention.
The 2 minute step in place test
The 2 minute step in place test (number): A test that measures the total number of times the right knee reaches the tape level in two minutes. The more number of reaches, the better fitness scores the participant has.
Time frame: The 2 minute step in place test will be conducted at baseline, mid-term survey, and within one week following the last session of the intervention.
The sit and reach test (cm)
The sit and reach test (cm) measures the distance reached by the hand. The participant sits on the floor with legs stretched out straight ahead, with the soles of the feet flat against the box. Both knees should be locked and pressed flat to the floor. Reach forward with a slow and steady movement as far as possible, and hold that position for three seconds while the distance is recorded. The larger scores indicate the better fitness of the participant.
Time frame: The sit and reach test will be conducted at baseline, mid-term survey, and within one week following the last session of the intervention.
Geriatic depression
Geriatric depression scale score ranges from 0-15 with higher scores indicating more severe depressive symptoms.
Time frame: Geriatric depression scale will be conducted at baseline and within one week following the last session of the intervention.
Pain related functional limitations
The brief version of the Western Ontario and McMaster Universities Osteoarthritis Index, which measures five items for pain (score range 0-20), two for stiffness (score range 0-8), and 17 for functional limitation (score range 0-68), with higher scores indicating worse pain and functional limitations in one's daily living.
Time frame: The WOMAC will be conducted at baseline and within one week following the last session of the intervention.
The Pittsburgh Sleep Quality Index (PSQI)
The brief version of the Pittsburgh Sleep Quality Index ranges from 0 to 15 with higher score indicating more sleep problems.
Time frame: The PSQI will be conducted at baseline, mid-term survey, and within one week following the last session of the intervention.
The Morse Fall Risk Scale
The Morse Fall Risk Scale ranges 0-125 with higher score indicating higher risk of fall.
Time frame: The system usability test will be conducted at baseline and within one week following the last session of the intervention.
WHO quality of life bref
WHO quality of life bref assesses physical, psychological, social, environmental health, which ranges 7-35, 6-30, 3-15, 8-40, respectively, higher score indicating better physical, psychological, social, environmental health status.
Time frame: The system usability test will be conducted at baseline and within one week following the last session of the intervention.
System Usability Test
System usability test will be conducted to examine changes in the levels of usability for the digital devices that were developed for the intervention program.
Time frame: The system usability test will be conducted at baseline, mid-term survey, and within one week following the last session of the intervention.
Plan to share: No — The IRB approval of this study do not allow sharing data from this study with other researchers.
Started Jan 2024 (actual). Primary completion is estimated for Dec 2026, 35 months after the start.
Of 862 non-industry interventional studies with no phase under Dementia, half reached primary completion within 25 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 44. This study's planned 35 months is above that.
Counting every sponsor, half of 908 studies reached it within 25 months; a quarter within 11 and three quarters within 43.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Sunmi Song